AKBA

NASDAQStock

Akebia Therapeutics, Inc.

$1.40+0.00 (+0.00%)

52-Week Range

$1.18
$4.01

Key Stats

Market Cap

375.0M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.40

Volume

2.2M

Avg Volume

3.2M

Performance

1M

-9.68%

3M

-13.04%

6M

-52.05%

YTD

-9.68%

1Y

-17.16%

3Y

+104.92%

5Y

-61.11%

Price Chart

ETF Exposure

AKBA is held by 51 ETFs

ETFFund NameWeight
QQQSInvesco NASDAQ Future Gen 200 ETF0.42%
PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF0.26%
SBIOALPS Medical Breakthroughs ETF0.23%
XBIState Street SPDR S&P Biotech ETF0.14%
VFMFVanguard U.S. Multifactor ETF0.07%
IWCiShares Micro-Cap ETF0.07%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.06%
VFMOVanguard U.S. Momentum Factor ETF0.04%
FESMFIDELITY ENHANCED SMALL CAP ETF0.04%
LABUDirexion Daily S&P Biotech Bull 3X ETF0.03%
PWSPacer WealthShield ETF0.03%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.02%
AVSCAvantis U.S. Small Cap Equity ETF0.02%
IWNiShares Russell 2000 Value ETF0.02%
SMLFiShares U.S. Small-Cap Equity Factor ETF0.02%
VTWVVanguard Russell 2000 Value ETF0.02%
IWMiShares Russell 2000 ETF0.01%
RESMColumbia Research Enhanced Small Cap ETF0.01%
VTWOVanguard Russell 2000 ETF0.01%
RSSLGlobal X - Russell 2000 ETF0.01%
SCHASchwab U.S. Small-Cap ETF0.01%
UWMProShares - Ultra Russell20000.01%
URTYProShares - UltraPro Russell20000.01%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.01%
VHTVanguard Health Care ETF0.01%
VXFVanguard Extended Market ETF0.01%
SMMDiShares Russell 2500 ETF0.00%
VTWGVanguard Russell 2000 Growth ETF0.00%
HDGProShares - Hedge Replication ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
DCORDimensional - US Core Equity 1 ETF0.00%
DFACDimensional - US Core Equity 2 ETF0.00%
DFAUDimensional - US Core Equity Market ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
IWViShares Russell 3000 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
Page 1 of 2Next

About AKBA ETF Exposure

Akebia Therapeutics, Inc. (AKBA) is held by 51 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 375.0M, AKBA is a widely held institutional stock. The stock currently trades at $1.40. Investors can gain exposure to AKBA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AKBA, sorted by portfolio weight.